Replimune
All
Newsflash
Article
-
Replimune wins FDA approval for its skin cancer drug, but shares tumble
Replimune has received FDA approval for its skin cancer drug, marking a successful third attempt to gain clearance. Despite the approval, the company's shares are tumbling.
-
Replimune wins FDA approval for its skin cancer drug, but shares tumble
Replimune has received FDA approval for its skin cancer drug, marking a successful third attempt to gain clearance. Despite the approval, the company's shares are tumbling.
- No data
Replimune
Svmuu provides news and information related to Replimune, as well as real-time data on Replimune. We provide in-depth analysis and interpretation of the latest Replimune developments, helping investors stay informed about Replimune policy updates. Svmuu is your essential tool for keeping up with the latest Replimune trends! Here, we’ll join you in keeping a close eye on Replimune news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
ZEC (Zcash) is up 6.26% over the past 4 hours, currently trading at $1,330.13.
-
2
The Shanghai Composite Index fell 1.06% from its previous close, currently trading at 3,650.85.
-
3
AUD/USD fell 0.89% from its previous close, currently trading at 0.6946.
-
4
Taiwan Stock Exchange Weighted Index fell 6.11% from its previous close, currently trading at 39,032.95.
-
5
The Nikkei 225 Index fell 5.76% from its previous close, currently trading at 57,557.09.
-
6
Brent crude was up 3.52% from its previous close, currently trading at $98.354.
-
7
South Korea's KOSPI index fell 5.48% from its previous close, currently standing at 5,088.79.
-
8
What is MTH (Monetha)? Project Positioning and Token Supply Analysis
-
9
Trump's policies and institutional participation drove Ethereum's sharp rally in August 2026, with its market cap reaching approximately $294.8 billion in November
-
10
Where to Buy MANA? A Comprehensive Guide to Decentraland Tokens and Mainstream Trading Channels
Markets Today
Recommended Reading


